• Publications
  • Influence
Screening utility of the Montreal Cognitive Assessment (MoCA): in place of – or as well as – the MMSE?
  • A. Larner
  • Medicine
  • International Psychogeriatrics
  • 3 October 2011
ABSTRACT Background: This aim of this study was to assess the clinical utility of the Montreal Cognitive Assessment (MoCA) as a screening instrument for cognitive impairment in patients referred to aExpand
  • 155
  • 10
Language function and dysfunction in corticobasal degeneration
Reply from the Authors: We appreciate Drs. Bushara and Hallett’s comments. We agree that their data and our data show a roughly equal prevalence of AGA in hereditary and sporadic ataxia patients.Expand
  • 69
  • 8
Comparing Diagnostic Accuracy of Cognitive Screening Instruments: A Weighted Comparison Approach
  • A. Larner
  • Psychology, Medicine
  • Dementia and Geriatric Cognitive Disorders Extra
  • 1 March 2013
Background/Aims: There are many cognitive screening instruments available to clinicians when assessing patients' cognitive function, but the best way to compare the diagnostic utility of these testsExpand
  • 36
  • 5
Epileptic Seizures in AD Patients
  • A. Larner
  • Psychology, Medicine
  • NeuroMolecular Medicine
  • 1 March 2010
Epileptic seizures have long been recognised as a complication of the clinical syndrome of Alzheimer’s disease, particularly in advanced disease, but have hitherto been viewed essentially asExpand
  • 102
  • 4
The cerebellum in Alzheimer's disease.
  • A. Larner
  • Psychology, Medicine
  • Dementia and geriatric cognitive disorders
  • 13 June 1997
The cerebellum is a relatively neglected area of the Alzheimer's disease (AD) brain, probably because it was formerly thought to be spared by the disease. However, a number of pathological changesExpand
  • 111
  • 4
A meta-analysis of the accuracy of the Addenbrooke's Cognitive Examination (ACE) and the Addenbrooke's Cognitive Examination-Revised (ACE-R) in the detection of dementia
ABSTRACT Background: The Addenbrooke's Cognitive Examination (ACE) and its Revised version (ACE-R) are relatively new screening tools for cognitive impairment that may improve upon the well-knownExpand
  • 69
  • 4
An effective immunotherapy regimen for VGKC antibody-positive limbic encephalitis
Background Voltage-gated potassium channel antibody-positive limbic encephalitis (VGKC+LE) frequently improves with immunotherapy, although the optimum regimen is unknown. The effectiveness of aExpand
  • 90
  • 3
False localising signs
  • A. Larner
  • Medicine
  • Journal of neurology, neurosurgery, and…
  • 1 April 2003
Neurological signs have been described as “false localising” if they reflect dysfunction distant or remote from the expected anatomical locus of pathology, hence challenging the traditionalExpand
  • 69
  • 3
  • PDF
...
1
2
3
4
5
...